DK104513C - Fremgangsmåde til fremstilling af tetraethoxybenzal-tetrahydro-isoquinolinderivater eller syreadditionssalte deraf. - Google Patents
Fremgangsmåde til fremstilling af tetraethoxybenzal-tetrahydro-isoquinolinderivater eller syreadditionssalte deraf.Info
- Publication number
- DK104513C DK104513C DK379862AA DK379862A DK104513C DK 104513 C DK104513 C DK 104513C DK 379862A A DK379862A A DK 379862AA DK 379862 A DK379862 A DK 379862A DK 104513 C DK104513 C DK 104513C
- Authority
- DK
- Denmark
- Prior art keywords
- tetraethoxybenzal
- preparation
- acid addition
- addition salts
- tetrahydroisoquinoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUCI000380 | 1961-08-30 | ||
| HUCI000390 | 1962-04-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK104513C true DK104513C (da) | 1966-05-31 |
Family
ID=26318367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK379862AA DK104513C (da) | 1961-08-30 | 1962-08-29 | Fremgangsmåde til fremstilling af tetraethoxybenzal-tetrahydro-isoquinolinderivater eller syreadditionssalte deraf. |
Country Status (5)
| Country | Link |
|---|---|
| CH (3) | CH425793A (de) |
| DK (1) | DK104513C (de) |
| FI (1) | FI40718B (de) |
| FR (1) | FR2057M (de) |
| GB (1) | GB1011554A (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103694171B (zh) * | 2013-12-13 | 2016-06-29 | 浙江普洛康裕制药有限公司 | 盐酸屈他维林晶型iii和晶型iv及其制备方法 |
| CN103664781B (zh) * | 2013-12-13 | 2015-12-09 | 浙江普洛康裕制药有限公司 | 盐酸屈他维林晶型i和晶型ii及制备方法 |
-
1962
- 1962-08-17 CH CH781566A patent/CH425793A/de unknown
- 1962-08-17 CH CH987462A patent/CH424782A/de unknown
- 1962-08-17 CH CH781466A patent/CH424783A/de unknown
- 1962-08-21 GB GB32120/62A patent/GB1011554A/en not_active Expired
- 1962-08-29 DK DK379862AA patent/DK104513C/da active
- 1962-08-29 FR FR908103A patent/FR2057M/fr active Active
- 1962-08-30 FI FI1593/62A patent/FI40718B/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| FI40718B (de) | 1969-01-31 |
| GB1011554A (en) | 1965-12-01 |
| CH424783A (de) | 1966-11-30 |
| CH425793A (de) | 1966-12-15 |
| CH424782A (de) | 1966-11-30 |
| FR2057M (fr) | 1963-10-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK104460C (da) | Fremgangsmåde til fremstilling af 2-methyl-3-hydroxypyridiner eller syreadditionssalte deraf. | |
| DK103079C (da) | Fremgangsmåde til fremstilling af 4-amino-quinolinforbindelser eller syreadditionssalte deraf. | |
| DK105205C (da) | Fremgangsmåde til fremstilling af pyridyl- eller pyrazyloxyalkylaminoalkylaminer eller syreadditionssalte heraf. | |
| DK106146C (da) | Fremgangsmåde til fremstilling af aminoquinolinderivater eller syreadditionssalte deraf. | |
| DK103672C (da) | Fremgangsmåde til fremstilling af phenylpropanolaminer eller syreadditionssalte heraf. | |
| DK108152C (da) | Fremgangsmåde til fremstilling af piperidylidenthioxanthenderivater eller syreadditionssalte deraf. | |
| DK104513C (da) | Fremgangsmåde til fremstilling af tetraethoxybenzal-tetrahydro-isoquinolinderivater eller syreadditionssalte deraf. | |
| DK103941C (da) | Fremgangsmåde til fremstilling af 3-thiocarbamoyl-phenthiazinforbindelser eller syreadditionssalte deraf. | |
| DK110091C (da) | Fremgangsmåde til fremstilling af substituerede diphenylalkylaminer eller syreadditionssalte heraf. | |
| DK102807C (da) | Fremgangsmåde til fremstilling af substituerede diphenylalkenylaminer eller syreadditionssalte heraf. | |
| DK118189B (da) | Analogifremgangsmåde til fremstilling af benzyloxyaminer eller syreadditionssalte heraf. | |
| DK129714B (da) | Fremgangsmåde til fremstilling af benzimidazolinoner eller syreadditionssalte deraf. | |
| DK103023C (da) | Fremgangsmåde til fremstilling af 5-aryl-benzodiazepinforbindelser eller syreadditionssalte deraf. | |
| DK103077C (da) | Fremgangsmåde til fremstilling af 4-hydroxyphenyl-4-carbalkoxy-piperidinderivater eller syreadditionssalte deraf. | |
| DK102681C (da) | Fremgangsmåde til fremstilling af 1-fenyl-2-aminoætanolderivater eller syreadditionssalte heraf. | |
| DK102632C (da) | Fremgangsmåde til fremstilling af 1-fenyl-2-aminoætanolderivater eller syreadditionssalte deraf. | |
| DK102471C (da) | Fremgangsmåde til fremstilling af 1-fenyl-2-aminoætanolderivater eller syreadditionssalte deraf. | |
| DK102682C (da) | Fremgangsmåde til fremstilling af 1-fenyl-2-aminoætanolderivater eller syreadditionssalte deraf. | |
| DK101066C (da) | Fremgangsmåde til fremstilling af dihalogenaminobenzylaminer eller syreadditionssalte heraf. | |
| DK104988C (da) | Fremgangsmåde til fremstilling af thenylguanidiner eller syreadditionssalte heraf. | |
| DK102575C (da) | Fremgangsmåde til fremstilling af N-benzodioxylurethaner eller syreadditionssalte heraf. | |
| DK102517C (da) | Fremgangsmåde til fremstilling af dihydrodibenzocyclohetener eller syreadditionssalte heraf. | |
| DK101795C (da) | Fremgangsmåde til fermstilling af dihalogenaminobenzylaminer eller syreadditionssalte heraf. | |
| DK101301C (da) | Fremgangsmåde til fremstilling af dihalogenaminobenzylaminer eller syreadditionssalte heraf. | |
| DK99268C (da) | Fremgangsmåde til fremstilling af aminobenzoksacykloalkaner eller syreadditionssalte deraf. |